엔에이치스팩29호

Business Overview

NHSPAC29 is a merger-arbitrage company established in January 2023, with the sole purpose of merging with companies listed on the Korea Exchange (KOSDAQ or KOSPI). The merger process follows procedures under the Commercial Code and Capital Market Act, including board resolutions, disclosures, and submission of securities registration documents. The target company will be dissolved post-merger, leaving NHSPAC29 as the surviving entity. The company must complete merger registration within the statutory deadline and undergo pre-listing reviews and shareholder meetings.